Historically, most people started HIV treatment with two drugs from the NRTI class combined with either one NNRTI, one protease inhibitor or one integrase inhibitor – hence, ‘triple therapy’.
This panel included the divalent cation chelator EDTA (1 mM), HALT pan-protease inhibitor cocktail (1x), the pan-dipeptidyl peptidase inhibitor talabostat (10 µM), and the serine hydrolase inhibitor ...